Skip Navigation



eCAM Advance Access published online on June 8, 2006
eCAM, doi:10.1093/ecam/nel025
This Article
Right arrow Full Text (PDF) Freely available
Right arrowOA All Versions of this Article:
3/3/359    most recent
nel025v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Nozaki, K.
Right arrow Articles by Shimada, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nozaki, K.
Right arrow Articles by Shimada, Y.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author (2006). Published by Oxford University Press. All rights reserved.

Original Article

Keishibukuryogan (Gui-Zhi-Fu-Ling-Wan), a Kampo Formula, Decreases Disease Activity and Soluble Vascular Adhesion Molecule-1 in Patients with Rheumatoid Arthritis

Kazuya Nozaki 1, Hiroaki Hikiami 1 *, Hirozo Goto 2, Takako Nakagawa 2, Naotoshi Shibahara 3, and Yutaka Shimada 4

1 Department of Japanese Oriental Medicine, Faculty of Medicine, University of Toyama, Toyama, Japan
2 Department of Kampo Diagnostics, Institute of Natural Medicine, University of Toyama, Toyama, Japan
3 Department of Kampo Diagnostics, Institute of Natural Medicine, University of Toyama, Toyama, Japan; 21st Century COE Program, University of Toyama, Toyama, Japan
4 Department of Japanese Oriental Medicine, Faculty of Medicine, University of Toyama, Toyama, Japan; 21st Century COE Program, University of Toyama, Toyama, Japan

* To whom correspondence should be addressed.
Hiroaki Hikiami, E-mail: ami3{at}med.u-toyama.ac.jp


  Abstract

An increasing death rate due to cardiovascular disease in patients with rheumatoid arthritis (RA) has been reported. Keishibukuryogan (KBG) is a traditional Chinese/Japanese (Kampo) formula that has been administered to patients with blood stagnation, e.g. thrombotic disease and atherosclerosis. The objective of this study was to evaluate the efficacy of KBG on disease activity and endothelial dysfunction in RA patients. Sixteen RA patients were enrolled and administered KBG (12 g per day) for 12 weeks in addition to continuing other drugs. The disease activity of RA was assessed by modified disease activity scores for 28 joints (DAS28). Plasma levels of adhesion molecules, soluble E-selectin (sE-selectin), soluble intercellular adhesion molecule-1 (sICAM-1) and soluble vascular cell adhesion molecule-1 (sVCAM-1) were evaluated. C-reactive protein (CRP), inflammatory cytokines (IL-1{beta}, IL-6 and TNF-{alpha}) and lipid peroxide (LPO) were also evaluated. Fourteen patients completed the study. The disease activity of RA, tender joint count, swollen joint count and DAS28 decreased significantly. Among adhesion molecules, only sVCAM-1 decreased significantly. LPO also decreased significantly, whereas CRP and inflammatory cytokines remained unchanged. These results suggest that KBG has insufficient anti-inflammatory or immunomodulating effect but does have a beneficial effect on articular symptoms and a protective effect against endothelial dysfunction in RA patients.

Keywords: antioxidant; lipid peroxide; vascular cell adhesion molecule-1.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Evid Based Complement Alternat MedHome page
N. P. Visavadiya and A. V. R. L. Narasimhacharya
Asparagus Root Regulates Cholesterol Metabolism and Improves Antioxidant Status in Hypercholesteremic Rats
Evid. Based Complement. Altern. Med., June 1, 2009; 6(2): 219 - 226.
[Abstract] [Full Text] [PDF]

Home page
 Evid Based Complement Alternat MedHome page
I. Lampronti, M. T.H. Khan, M. Borgatti, N. Bianchi, and R. Gambari
Inhibitory Effects of Bangladeshi Medicinal Plant Extracts on Interactions between Transcription Factors and Target DNA Sequences
Evid. Based Complement. Altern. Med., September 1, 2008; 5(3): 303 - 312.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
M. Fujimoto, K. Tsuneyama, M. Kainuma, N. Sekiya, H. Goto, Y. Takano, K. Terasawa, C. Selmi, M. E. Gershwin, and Y. Shimada
Evidence-Based Efficacy of Kampo Formulas in a Model of Non Alcoholic Fatty Liver
Experimental Biology and Medicine, March 1, 2008; 233(3): 328 - 337.
[Abstract] [Full Text] [PDF]

Home page
 Evid Based Complement Alternat MedHome page
H. Liao, L. K. Banbury, and D. N. Leach
Elucidation of Danzhixiaoyao Wan and Its Constituent Herbs on Antioxidant Activity and Inhibition of Nitric Oxide Production
Evid. Based Complement. Altern. Med., December 1, 2007; 4(4): 425 - 430.
[Abstract] [Full Text] [PDF]

Home page
 Evid Based Complement Alternat MedHome page
S.-C. Chun, S. Y. Jee, S. G. Lee, S. J. Park, J. R. Lee, and S. C. Kim
Anti-Inflammatory Activity of the Methanol Extract of Moutan Cortex in LPS-Activated Raw264.7 Cells
Evid. Based Complement. Altern. Med., September 1, 2007; 4(3): 327 - 333.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.